Breakthrough Designation for BONESUPPORT CERAMENT V for Bone Infection


BONESUPPORT’s antibiotic-eluting product, CERAMENT V, has received categorization as a Breakthrough Device for the indication bone infection by FDA.

CERAMENT V is an injectable synthetic bone void filler comprising 40% hydroxyapatite, 60% calcium sulfate and the antibiotic vancomycin hydrochloride.

The ratio of hydroxyapatite and calcium...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us